Success Metrics

Clinical Success Rate
96.8%

Based on 91 completed trials

Completion Rate
97%(91/94)
Active Trials
10(8%)
Results Posted
11%(10 trials)
Terminated
3(2%)

Phase Distribution

Ph phase_2
6
5%
Ph phase_3
3
2%
Ph not_applicable
89
72%
Ph phase_4
10
8%
Ph early_phase_1
2
2%
Ph phase_1
9
7%

Phase Distribution

11

Early Stage

6

Mid Stage

13

Late Stage

Phase Distribution119 total trials
Early Phase 1First-in-human
2(1.7%)
Phase 1Safety & dosage
9(7.6%)
Phase 2Efficacy & side effects
6(5.0%)
Phase 3Large-scale testing
3(2.5%)
Phase 4Post-market surveillance
10(8.4%)
N/ANon-phased studies
89(74.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.8%

91 of 96 finished

Non-Completion Rate

5.2%

5 ended early

Currently Active

10

trials recruiting

Total Trials

123

all time

Status Distribution
Active(13)
Completed(91)
Terminated(5)
Other(14)

Detailed Status

Completed91
unknown14
Recruiting8
Not yet recruiting3
Terminated3
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
123
Active
10
Success Rate
96.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (1.7%)
Phase 19 (7.6%)
Phase 26 (5.0%)
Phase 33 (2.5%)
Phase 410 (8.4%)
N/A89 (74.8%)

Trials by Status

active_not_recruiting22%
not_yet_recruiting32%
recruiting87%
terminated32%
completed9174%
unknown1411%
withdrawn22%

Recent Activity

Clinical Trials (123)

Showing 20 of 123 trialsScroll for more
NCT04966299Not Applicable

Effect of Daily Erythritol Versus Sucrose Intake Over 5 Weeks on Glucose Tolerance in Adolescents

Active Not Recruiting
NCT06799715Not Applicable

Assessments of Metabolic Responses to Acute Oral Administration of Sucrose, Glucose, and Fructose

Active Not Recruiting
NCT06424106Not Applicable

Effect of Glucagon on Fasting Insulin Secretion and Glucose Metabolism in Subjects Without Type 2 Diabetes

Recruiting
NCT06373016Not Applicable

Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder

Recruiting
NCT07479251Not Applicable

Glycaemic Index Measurement of an Oral Nutritional Supplement With Biomarker Assessment and Lifestyle Monitoring in Healthy Participants

Not Yet Recruiting
NCT07435480

Irisin Hormone as a Novel Diagnostic Marker for Detection and Progression of Diabetic Nephrophathy Patients

Not Yet Recruiting
NCT06329544Not Applicable

High Fructose Diet, the Gut Microbiome, and Metabolic Health

Recruiting
NCT06955130Not Applicable

Lactate and Glycerol Contribution to Gluconeogenesis

Not Yet Recruiting
NCT06638190Not Applicable

Influence of the Fruit Matrix on Glucose and Insulin Responses After the Intake of Orange Juice in Healthy Human Males

Completed
NCT07013916Not Applicable

Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)

Recruiting
NCT07014735Not Applicable

Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM

Recruiting
NCT06714552Not Applicable

Effect of a Sugar Replacement on Blood Glucose Levels in Healthy Adults

Recruiting
NCT02180412Phase 2

Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria

Completed
NCT02902198Not Applicable

Taste Physiology in Obese Volunteers Before and After Bariatric Surgery

Recruiting
NCT05287906Not Applicable

A Trial to Assess Steviol Glycosides on Acute Appetite Hormone Release

Completed
NCT06358716Not Applicable

Glycaemic Index Determination in Oral Nutrition Supplements

Recruiting
NCT05615012Phase 1

A Study Investigating Interactions Between BMS-986322 and Rosuvastatin, Metformin and Methotrexate in Healthy Participants

Completed
NCT05941806Phase 3

Prophylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Retention in Men After Rectum Resection

Unknown
NCT05335863Not Applicable

Glycemic Index Evaluation of a Hypercaloric/High-protein Nutritional Supplement in Healthy Adults

Completed
NCT04840095Phase 4

Dynamic Connectivity Under Metabolic Constraints

Unknown

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
123